B NTech reports that the first results of the anticontour vaccine emerge in July

“The clinical studies on volunteers, which are under way in Germany and the United States, are intended to determine the security, efficiency, and opitation of four possible vaccines against Coronavirus”, the executive director, Ugur Sahin, said.

“BioNTech”, in Germany and “Pfizer” are co-operating to create production capacity, in the hope that millions of doses of a vaccine may be available by the end of this year if it gets the necessary approval from the regulatory entity.

In Europe, 200 healthy volunteers between the ages of 18 and 55 are part of the tests. In the United States, about 360 healthy volunteers will be vaccinated, initially only with subjects between the ages of 18 and 55, but later with older volunteers.